Enterprise League logo
Starlight Therapeutics Logo

Starlight Therapeutics

Plano, United States (US) · Health and Medical

We built this page from public sources. What we do with your data

Do you work at Starlight Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#brain cancer research

#cns cancer research

#clinical trials

#clinical development

#biotechnology

#cancer drug development

#oncology

#precision medicine

#biomarkers

#genetic screen

Starlight Therapeutics is a US-based biotechnology company specializing in the development of innovative therapies for **CNS cancers**, particularly brain cancers.We are dedicated to addressing the significant unmet medical needs of patients facing challenging diagnoses such as glioblastoma, brain metastases, and atypical teratoid rhabdoid tumors (ATRT).

Overview

Starlight Therapeutics is a US-based biotechnology company specializing in the development of innovative therapies for **CNS cancers**, particularly brain cancers.

We are dedicated to addressing the significant unmet medical needs of patients facing challenging diagnoses such as glioblastoma, brain metastases, and atypical teratoid rhabdoid tumors (ATRT). Our research focuses on **precision oncology**, leveraging AI-powered innovation to identify and develop targeted treatments.

Starlight Therapeutics is currently focused on advancing our lead drug candidate, STAR-001, through **clinical trials** and preclinical development, with the goal of significantly improving patient outcomes in these devastating diseases.

We are a rapidly growing team of scientists and clinicians committed to lighting the way in **brain and CNS cancer treatment**.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@starlightthera.com

Plano, United States (US), 7700 Windrose Ave

Company Type

Private Limited Company

Employees

2-10

Categories

Biopharma
Life Science
Biotechnology

Keywords

#brain cancer research

#cns cancer research

#clinical trials

#clinical development

#biotechnology

#cancer drug development

#oncology

#precision medicine

#biomarkers

#genetic screen

Awards

• 2026 OpenSee all

Products

Default Product Image
STAR-001
Biotechnology

STAR-001 is Starlight Therapeutics’ lead drug candidate, a novel therapeutic agent being developed for the treatment of CNS cancers, including glioblastoma, brain metastases, and ATRT.

N/A

Companies teams usually look at after Starlight Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.